.ALX Oncology's phase 2 stomach cancer cells reaction cost has actually compromised. After seeing it...
.One More of Ionis Pharmaceuticals' key midphase readouts has actually disappointed expectations, ur...
.While Biogen's pharma peers are searching for late-stage resources along with little risk, CEO Chri...
.Instil Bio has been a biotech in search of a pipeline after it junked its own lead possessions over...
.Biogen has restored rights to an early Alzheimer's ailment program to Denali Rehabs, leaving a siza...
.Invite to recently's Chutes & Ladders, our roundup of significant leadership hirings, shootings ...
.Vertex's effort to address a rare hereditary illness has actually reached one more problem. The bio...
.Vir Biotechnology's second-quarter incomes record had not been short of large headlines. The provid...
.Galapagos has paused enrollment in a test of a BCMA-directed CAR-T tissue therapy, pumping the brak...
.After much more than three decades, gene therapy trailblazer James Wilson M.D., Ph.D., is actually ...